Company
|
||||||
---|---|---|---|---|---|---|
Exact Sciences
EXAS
|
NASDAQ
|
USA
|
Healthcare
|
53.43
$
|
-0.95
%
|
10.35B
$
|
![]()
Insmed
INSM
|
NASDAQ
|
USA
|
Healthcare
|
145.93
$
|
-1.91
%
|
11.33B
$
|
![]()
Summit Therapeutics
SMMT
|
NASDAQ
|
UK
|
Healthcare
|
18.94
$
|
-
|
12.82B
$
|
BioMarin Pharmaceutical
BMRN
|
NASDAQ
|
USA
|
Healthcare
|
54.09
$
|
-1.76
%
|
12.93B
$
|
Sarepta Therapeutics
SRPT
|
NASDAQ
|
USA
|
Healthcare
|
17.39
$
|
0.46
%
|
13.12B
$
|
![]()
Genmab AS
GMAB
|
NASDAQ
|
USA
|
Healthcare
|
27.82
$
|
0.61
%
|
13.49B
$
|
Neurocrine Biosciences
NBIX
|
NASDAQ
|
USA
|
Healthcare
|
141.87
$
|
-1.01
%
|
14.16B
$
|
Incyte
INCY
|
NASDAQ
|
USA
|
Healthcare
|
83.14
$
|
0.05
%
|
14.54B
$
|
Royalty Pharma Plc
RPRX
|
NASDAQ
|
USA
|
Healthcare
|
36.36
$
|
-3.33
%
|
15.12B
$
|
Moderna
MRNA
|
NASDAQ
|
USA
|
Healthcare
|
23.88
$
|
1.57
%
|
15.97B
$
|
![]()
Avacta Group PLC
AVCT
|
LSE
|
UK
|
Healthcare
|
55
£
|
-1.82
%
|
16.35B
£
|
United Therapeutics
UTHR
|
NASDAQ
|
USA
|
Healthcare
|
405.02
$
|
-0.47
%
|
17.11B
$
|
4BASEBIO UK SOCIETAS
4BB
|
LSE
|
UK
|
Healthcare
|
840
£
|
-
|
18.72B
£
|
BeiGene, Ltd.
ONC
|
NASDAQ
|
USA
|
Healthcare
|
324.34
$
|
2.44
%
|
19.45B
$
|
Natera
NTRA
|
NASDAQ
|
USA
|
Healthcare
|
168.51
$
|
2.17
%
|
19.74B
$
|
Biogen
BIIB
|
NASDAQ
|
USA
|
Healthcare
|
144.86
$
|
-1.06
%
|
22.31B
$
|
Biodexa Pharmaceticals
BDRX
|
NASDAQ
|
USA
|
Healthcare
|
6.03
$
|
0.17
%
|
27.08B
$
|
![]()
BioNTech SE
BNTX
|
NASDAQ
|
USA
|
Healthcare
|
96.74
$
|
1.18
%
|
27.37B
$
|
Alnylam Pharmaceuticals
ALNY
|
NASDAQ
|
USA
|
Healthcare
|
461.14
$
|
-1.02
%
|
30.04B
$
|
![]()
argenx NV ADR
ARGX
|
NASDAQ
|
USA
|
Healthcare
|
756.38
$
|
0.06
%
|
40.08B
$
|